A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...

How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...

Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business ...

On sickle cell, Q4 framed the pre-sNDA meeting as pending to define pathway, while Q1 updated to a specific action and timing: CEO Goff said Agios “plan [s] to submit an sNDA…in the second quarter ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

A startup out of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually ...

Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry oxygen to tissues, even after shedding the vital structures they need to ...

Agios Pharmaceuticals faces major competitive and regulatory headwinds in sickle cell disease and thalassemia, leading to a rating downgrade to a cautious 'Hold.' Novo Nordisk's PK activator looks ...

Every day the human body replaces billions of cells, flushing out the old and generating the new, healthy ones. The average lifespan of a red blood cell is just under four months, while skin cells ...